Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Brandon

Malcolm Brandon, Victoria AU

Patent application numberDescriptionPublished
20080199491Sustained Release Vaccine Composition - A non-liquid vaccine composition including one or more antigen component(s); a pharmaceutically acceptable non-liquid adjuvant therefor; and optionally a non-liquid vaccine protection agent.08-21-2008

Malcolm Brandon, Balwyn AU

Patent application numberDescriptionPublished
20110142901SUSTAINED RELEASE COMPOSITION - A sustained release apparatus including at least one sustained release mini-implant or pellet; the or each mini-implant or pellet including: a sustained release support material; and a pharmaceutical composition including a Luteinising Hormone Releasing Hormone (HLRH) agonist and/or antagonist component the size and/or number and/or payload of mini-implant(s) or pellet(s) providing, release of LHRH agonist and/or antagonist at, or above, a desired threshold level for treatment of a selected indication, the apparatus providing approximately zero order release of the LHRH agonist and/or antagonist.06-16-2011

Malcolm Roy Brandon, Melbourne AU

Patent application numberDescriptionPublished
20110217366IMMUNOPOTENTIATING COMPOSITION - The present invention provides an immunopotentiating composition which comprises an antigen or antigen-inducing substance, and a carrier comprising a biocompatible material for effectively increasing an immune response derived from an antigen. The present invention further provides a method of producing an antibody by administering said immunopotentiating composition to a mammal or bird, thereby modulating the immune response in said mammal or bird and recovering the antibody produced.09-08-2011

Mark Phillip Brandon, Toronto CA

Patent application numberDescriptionPublished
20120090765APPARATUS FOR HEATING OF ELONGATE TUBULAR ARTICLE - The invention is directed to an apparatus for heating an elongate tubular article, comprising a frame member adapted to be disposed around said article, a heater with multiple heating zones and a controller for operating the heating device. The apparatus may be used to apply a heat shrinkable sleeve around a welded pipe joint. The heater may be infrared and also may use thin stamped sheets. If a heat shrinkable sleeve is used, the controller may activate the heating zones from the centre of the weld outward to eliminate pockets of air. The diameter of the interior of the frame may change along the length of the frame.04-19-2012

Nick Brandon, Hertfordshire GB

Patent application numberDescriptionPublished
20110269782USE OF NMDA ACTIVITY ENHANCERS TO TREAT HYPERSOMNIA, REDUCED WAKEFULNESS OR REDUCED VIGILANCE - The present invention discloses the use of an enhancer of NMDA activity that acts via the glycine modulatory site to treat hypersomnia, reduced wakefulness or reduced vigilance as well as methods for preparing such compounds.11-03-2011

Nigel Brandon, Sutton GB

Patent application numberDescriptionPublished
20090194219 SOLID OXIDE FUEL CELL COMPONENT AND A METHOD OF MANUFACTURING A SOLID OXIDE FUEL CELL COMPONENT - A solid oxide fuel cell component (08-06-2009

Nigel Brandon, Surrey GB

Patent application numberDescriptionPublished
20100129727SOLID OXIDE FUEL CELL COMPONENT AND A METHOD OF MANUFACTURING A SOLID OXIDE FUEL CELL COMPONENT - A solid oxide fuel cell component (05-27-2010

Nigel Peter Brandon, Surrey GB

Patent application numberDescriptionPublished
20100028732METHOD AN APPARATUS FOR OPERATING A SOLID-OXIDE FUEL CELL STACK WITH A MIXED IONIC/ELECTRONIC CONDUCTING ELECTROLYTE - A method and apparatus for operating an intermediate-temperature solid-oxide fuel cell stack (02-04-2010

Richard Bruce Brandon, Brandon AU

Patent application numberDescriptionPublished
20110231106STATUS DETERMINATION - The present invention provides a method of determining the status of a subject. In particular, this is achieved by obtaining subject data including respective values for each of a number of parameters, the parameter values being indicative of the current biological status of the subject. The subject data is compared to predetermined data which includes values for at least some of the parameters and an indication of the condition. The status of the subject, and in particular, the presence and/or absence of the one or more conditions, can then be determined in accordance with the results of the comparison.09-22-2011

Richard Bruce Brandon, Queensland AU

Patent application numberDescriptionPublished
20080274988Microarray-Mediated Diagnosis of Herpes Virus Infection by Monitoring Host's Differential Gene Expression Upon Infection - The present invention discloses disease-associated molecules and assays, which are useful for diagnosing and assessing those animals with herpes virus infection, and determining those animals at risk of developing an herpes virus infection or its sequelae. The invention has practical use in the early diagnosis of disease, in monitoring an animal's immune response to the disease, and in enabling better treatment and management decisions to be made in clinically and sub-clinically affected animals.11-06-2008
20090081243Agents and methods for diagnosing stress - The present invention discloses molecules and assays for qualitatively or quantitatively determining the effect of stress on the immune system, the susceptibility to developing disease or illness through immune system dysfunction as a result of stress, and for monitoring the ability of an animal to cope with stress. The invention is useful inter alia in measuring response to immunomodulatory therapies, and monitoring the immune response to natural disease under stressful conditions.03-26-2009
20090264305Polynucleotide Marker Genes and their Expression, for Diagnosis of Endotoxemia - The present invention discloses disease-associated molecules and assays, which are useful for diagnosing and assessing those animals with endotoxemia, and determining those animals at risk of developing endotoxemia or its sequelae. The invention has practical use in the early diagnosis of disease, in monitoring an animal's immune response to the disease, and in enabling better treatment and management decisions to be made in clinically and sub-clinically affected animals.10-22-2009

Tyler Lee Brandon, Edmonton CA

Patent application numberDescriptionPublished
20090285035Pipelined wordline memory architecture - A method is provided for reducing semiconductor memory wordline propagation delays of long wordlines by inserting pipeline registers in the wordlines between groups of memory cells.11-19-2009